Insulin Degludec: A State-of-the-Art Basal Insulin

Duration

< 15 mins

Profession

Allied Health

Physician

Nursing

Specialist

Pharmacy

Student

Medical Resident

# of Credits

0.0

Accreditation

N/A

Expiry Date

2020-07-30

The DEVOTE study was a treat-to-target, randomized, double-blind, active comparator-controlled cardiovascular outcomes trial that compared the cardiovascular safety of insulin degludec with that of insulin glargine in patients with type 2 diabetes at high risk of cardiovascular events.

Unaccredited

Vincent Woo, MD, FRCPC

Gihane Zarifa, MD



Related Courses